642 / 864
641
Bibliografía
1. Staikuniene J, Staneviciute J. Long-term valacyclovir treatment and immune modulation for herpes-
associated erythema multiforme. Central European J Immunol 2015;40:387-90.
2. Sidner-Weintraub Y, Gross I, David A, Reif S, Molho-Pessach V. Paediatric erythema multiforme: epide-
miological, clinical and laboratory characteristics. Acta Derm Venereol 2017;97:489-92
3. Baillis B, Maize JC. Treatment of recurrent erythema multiforme with adalimumab as monotherapy. JAAD
2017;3:95-7.
4. Martínez-Cabriales S, Gómez-Flores M, Ocampo-Candiani J. News in severe adverse drug reactions:
Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Gac Med Mex 2015;151:721-31.
5. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between
clinical patterns and causes of erythema multiforme majus, Stevens Johnson syndrome and toxic epider-
mal necrolysis: results of an international prospective study. Arch Dermatol 2002;138:1019-24.